Skip to main content
Log in

Axitinib/Pembrolizumab

Immune-related hepatitis and cytokine release syndrome

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Yoshimura A, et al. Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy. International Cancer Conference Journal 13 : 26-32, Jan 2024. Available from: URL: https://dx.doi.org/10.1007/s13691-023-00630-w [summarised from an abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Axitinib/Pembrolizumab. Reactions Weekly 1992, 36 (2024). https://doi.org/10.1007/s40278-024-52769-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-024-52769-0

Navigation